Deborah Weitzman Cardinal Health Inc (CAH) insider trading activity
Deborah Weitzman is CEO, Pharmaceutical Segment of CARDINAL HEALTH INC. Currently has a direct ownership of 34,564 shares of CAH, which is worth approximately $3.43 Million. The most recent transaction as insider was on Dec 01, 2023, when has been sold 638 shares (Common Shares) at a price of $107.08 per share, resulting in proceeds of $68,317. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
34.6K
0%
3M change
28.39%
12M change
Total Value Held
$3.43 Million
DEBORAH WEITZMAN Transaction History
DW
Deborah Weitzman
CEO, Pharmaceutical Segment
Dublin, OH